Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.

Martiniano SL, Wagner BD, Levin A, Nick JA, Sagel SD, Daley CL. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection. Chest. 2017 10; 152(4):800-809.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Aged, 80 and over
Anti-Inflammatory Agents
Child
Clofazimine
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Male
Middle Aged
Mycobacterium Infections, Nontuberculous
Nontuberculous Mycobacteria
Pneumonia
Radiography, Thoracic
Retrospective Studies
Sputum
Treatment Outcome
Young Adult

authors with profiles

Charles L Daley
Jerry Allan Nick
Scott D Sagel
Brandie Dawn Wagner
Stacey L. Martiniano